Revisiting the design of phase III clinical trials...[PLoS Med. 2008]

SearchDatabase nameforSearch term

Advanced Search

Your browser version may not work well with NCBI's Web applications. More information here...

Display Show

All: 1

Review: 0

Click to change filter selection through MyNCBI.

1: PLoS Med. 2008 Nov 18;5(11):e227. Links

Comment in:: PLoS Med. 2008 Nov 18;5(11):e228.

Revisiting the design of phase III clinical trials of antimalarial drugs for uncomplicated Plasmodium falciparum malaria.

Borrmann S, Peto T, Snow RW, Gutteridge W, White NJ.

Steffen Borrmann is with the Kenya Medical Research Institute, Wellcome Trust Research Programme, Centre for Geographical Medicine Research, Coast, Kilifi, Kenya. sborrmann@kilifi.kemri-wellcome.org

PMID: 19018658 [PubMed - indexed for MEDLINE]

PMCID: PMC2586344

Comparing highly efficacious antimalarial drugs.
PLoS Med. 2008 Nov 18; 5(11):e228.

[PLoS Med. 2008]
The future outlook of antimalarial drugs and recent work on the treatment of malaria.
Arch Med Res. 2002 Jul-Aug; 33(4):416-21.

[Arch Med Res. 2002]
ReviewP. falciparum strain resistance to drugs. New drug trials.
Rev Inst Med Trop Sao Paulo. 1992 Apr; 34 Suppl 9:S10-5.

[Rev Inst Med Trop Sao Paulo. 1992]
ReviewEpidemiological distribution of Plasmodium falciparum drug resistance in Brazil and its relevance to the treatment and control of malaria.
Mem Inst Oswaldo Cruz. 1992; 87 Suppl 3:343-8.

[Mem Inst Oswaldo Cruz. 1992]
The response of a case of multidrug-resistant, Plasmodium falciparum malaria to an unusual combination of antimalarial drugs.
Ann Trop Med Parasitol. 2002 Jun; 96(4):417-8.

[Ann Trop Med Parasitol. 2002]
» See reviews... | » See all...

Cited by 1 PubMed Central article

The effect of varying analytical methods on estimates of anti-malarial clinical efficacy.
Verret WJ, Dorsey G, Nosten F, Price RN. Malar J. 2009 Apr 22; 8:77. Epub 2009 Apr 22.

[Malar J. 2009]

Recent Activity

Clear Turn Off Turn On

Revisiting the design of phase III clinical trials of antimalarial drugs for uncomplicated...Revisiting the design of phase III clinical trials of antimalarial drugs for uncomplicated Plasmodium falciparum malaria.

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Display Show

Revisiting the design of phase III clinical trials of antimalarial drugs for uncomplicated Plasmodium falciparum malaria.

Related articles

Cited by 1 PubMed Central article

Recent Activity